Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
22
Patentes de invención
22
Propiedad industrial
15
Patentes
11
Derechos de autor
8
Marcas de fábrica
5
Historia
4
México
3
Transferencia de tecnología
3
Aspectos ambientales
2
Biotecnología
2
Biotecnología agrícola
2
Ciencia
2
Criptografía
2
Genes
2
Ingeniería genética
2
Literatura española
2
Marcas
2
Monopolios
2
PATENTES
2
PATENTS
2
Patents
2
Propiedad intelectual
2
Universidades
2
ACADEMIC PRODUCTION
1
ACADEMIC WOMEN
1
ANÁLISIS BIBLIOMÉTRICO
1
Acuerdos (Derecho)
1
Administración pública
1
Agricultura
1
-
8541“…After controlling for potential confounding factors (small for gestational age, extra-uterine growth retardation at discharge, cerebral palsy, gender, mild intraventricular hemorrhage, persistent pulmonary hypertension of newborn, respiratory distress syndrome, chronic lung disease, hemodynamic significant patent ductus arteriosus, necrotizing enterocolitis, surfactant use and indomethacin use), post-discharge failure to thrive remained a risk factor. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8542por Gong, Eun Jeong, Lee, Ji Young, Bae, Suh Eun, Park, Young Soo, Choi, Kee Don, Song, Ho June, Lee, Gin Hyug, Jung, Hwoon-Yong, Jeong, Woo Jin, Cheon, Gab Jin, Yook, Jeong Hwan, Kim, Byung Sik“…RESULTS: The median age of the patients was 59.0 years, and 33.8% were female. The patents were grouped as follows: seronegative, 188 (20.5%); low-positive, 288 (31.4%); mid-positive, 290 (31.6%); and high-positive 151 (16.5%). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8543por Liu, Mingsu, Li, Guangqin, Tang, Jie, Liao, Yan, Li, Lin, Zheng, Yang, Guo, Tongli, Kang, Xin, Yuan, Maoting“…The natural course of stroke is worse in females than in males, but the evidence regarding sex disparities in the responses to thrombolysis in stroke patents is still controversial. We compared outcomes after thrombolysis treatment between females and males. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8544por Song, Ru-Xin, Cai, Shi-Feng, Ma, Shuang, Liu, Zhi-Ling, Gai, Yong-Hao, Zhang, Chun-Qing, Wang, Guang-Chuan“…HV lesions were classified as segmental stenosis, segmental occlusion, membranous stenosis, membranous occlusion, cord-like occlusion, or non-visualized. Except for patent IVCs, IVC lesions were classified as segmental occlusion, segmental stenosis, membranous occlusion, membranous stenosis, and hepatomegaly-induced stenosis. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8545por Jung, Yoon Suk, Park, Jung Ho, Park, Dong Il, Sohn, Chong Il, Lee, Jae Myun, Kim, Tae Il“…MATERIALS AND METHODS: A cross-sectional study was performed on 12014 asymptomatic examinees. Using a patented stimulatory cytokine, NK cell activity was quantitated by the amount of interferon-γ secreted into the plasma by NK cells. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8546“…However, the changes in software, even if the basic patented operational algorithm has not changed, may influence the measured values as shown in the present study. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8547“…Thirteen patients (42%) had no resorption, whereas 13 (42%) and 5 (16%) patents had <50% and ≥50% resorption, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8548por Castizo-Olier, Jorge, Irurtia, Alfredo, Jemni, Monèm, Carrasco-Marginet, Marta, Fernández-García, Raúl, Rodríguez, Ferran A.“…BACKGROUND: Bioelectrical impedance vector analysis (BIVA) is a general concept that includes all methodologies used in the analysis of the bioelectrical vector, whereas the "classic" BIVA is a patented methodology included among these methods of analysis. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8549“…In addition to these new anti-CD20 antibodies, another imminent change in targeted lymphoma treatment is the multitude of biosimilars that are becoming available as rituximab’s patent expires. While the widespread use of rituximab itself will likely continue, its biosimilars will increase global access to the therapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8550por Nayak, Seema, Bhatt, M. L. B., Goel, Madhu Mati, Gupta, Seema, Mahdi, Abbas Ali, Mishra, Anupam, Mehrotra, Divya“…TGM-3 expression was significantly associated with response to chemo-radiotherapy treatment (p<0.007) and overall survival (p<0.015). Patents having higher level of TGM-3 expression have good response to chemo-radiotherapy and also have better overall survival. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8551por Walder, Anna, Müller, Martin, Dahdal, Suzan, Sidler, Daniel, Devetzis, Vasilios, Leichtle, Alexander B., Fiedler, Martin G., Popp, Albrecht W., Lippuner, Kurt, Vogt, Bruno, Uehlinger, Dominik, Huynh-Do, Uyen, Arampatzis, Spyridon“…The forearm is also the site of previous created distal arteriovenous fistulas (AVF). Although AVF remain patent long after successful transplantation, there are no data available concerning their impact on radial bone DXA measurements. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8552por Luo, Tianhang, Zhao, Jiangman, Lu, Zhengmao, Bi, Jianwei, Pang, Tao, Cui, Hangtian, Yang, Biao, Li, Wushuang, Wang, Yu, Wu, Shouxin, Xue, Xuchao“…MEF2C-AS1 and FENDRR expression were re-evaluated by Real-time Quantitative PCR in 42 DGC patients' tumor and normal tissues, and other 46 DGC patents' and 21 healthy controls' plasma. Validation data showed MEF2C-AS1 and FENDRR were significantly downregulated in tumor tissues compared with normal tissues. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8553por Matsuoka, Yuji, Endo, Kenji, Suzuki, Hidekazu, Sawaji, Yasunobu, Nishimura, Hirosuke, Takamatsu, Taichiro, Kojima, Osamu, Murata, Kazuma, Seki, Takeshi, Horie, Shinji, Konishi, Takamitsu, Yamamoto, Kengo“…OVERVIEW OF LITERATURE: Postoperative early-onset ASD is one of the complications after L4–L5 PLIF, a common surgical procedure for lumbar degenerative disease in patents without severe sagittal imbalance. A better understanding of the preoperative characteristics of total spinal sagittal alignment associated with early-onset ASD could help prevent the condition. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8554por Duarte, Nádia, Coelho, Inês, Holovanchuk, Denys, Inês Almeida, Joana, Penha‐Gonçalves, Carlos, Paula Macedo, Maria“…Serum CD26/DPP‐4 is elevated when severe perturbations are imposed on KC populations, regardless of patent liver damage. We propose that serum CD26/DPP‐4 is a potential systemic surrogate marker of severe impairments in the KC population imposed by clinical and subclinical liver conditions.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8555por Rodi, Timo, Geierlehner, Alexander, Mosahebi, Afshin, Tanos, Grigorios, Wormald, Justin Conrad Rosen“…BACKGROUND: A patent microvascular anastomosis is of paramount importance in free tissue transfer. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8556por Taggart, David P., Webb, Carolyn M., Desouza, Anthony, Yadav, Rashmi, Channon, Keith M., De Robertis, Fabio, Di Mario, Carlo“…All failures were apparent at 1 year except for one additional nonstented failure at 4.5 years. In patent vein grafts, Fitzgibbon perfect patency remained significantly higher in the stented versus nonstented vein grafts (81 and 48% respectively, p = 0.002), while intimal hyperplasia area (4.27 mm(2) ± 1.27 mm(2) and 5.23 mm(2) ± 1.83 mm(2) respectively, p < 0.001) and thickness (0.36 mm ± 0.09 mm and 0.42 mm ± 0.11 mm respectively, p < 0.001) were significantly reduced. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8557por Chen, Ying, Fu, Lifeng, Han, Min, Jin, Meiying, Wu, Jiaying, Tan, Li, Chen, Zhong, Zhang, Xiangnan“…Corbrin Capsule, a preparation of Cordyceps sinensis analogue, is a pleiotropic traditional Chinese patent medicine with the main component of fermentative cordyceps fungus powder (Cs-C-Q80). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8558“…Both TAR and descending aorta stent grafting were significantly associated with decreased risk of patent false lumen. CONCLUSIONS: Proximal aortic replacement remains the preferred surgical strategy for acute type I aortic dissection, with lower mortality and neurological complications. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8559por Yadavali, R., Ananthakrishnan, G., Sim, M., Monaghan, K., McNaught, G., Hamoodi, I., Bryden, F., Lassman, S., Moss, J. G.“…All uterine arteries were patent at 24-h and 6 months. Complete (100%) fibroid infarction rates were 5(50%) and 2(20%) in the E and G groups respectively. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8560por Liang, Jin-Hua, Lu, Luo, Zhu, Hua-Yuan, Li, Wang, Fan, Lei, Li, Jian-Yong, Xu, Wei“…The overall response rate for all the 60 AITL patents were 71.7% (95% confidence interval [CI], 58.6 to 82.5) with 3-year progressive-free survival (PFS) rate of 30.9%±6.1% and overall survival (OS) rate of 60.1%±6.6%. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto